LANZARONE, NICOLA
 Distribuzione geografica
Continente #
EU - Europa 159
NA - Nord America 143
AS - Asia 30
SA - Sud America 9
AF - Africa 2
OC - Oceania 1
Totale 344
Nazione #
US - Stati Uniti d'America 142
IT - Italia 101
IE - Irlanda 15
GB - Regno Unito 12
FR - Francia 11
DE - Germania 10
VN - Vietnam 10
EC - Ecuador 6
SE - Svezia 5
CN - Cina 4
KR - Corea 4
ID - Indonesia 3
IN - India 3
JP - Giappone 3
BE - Belgio 2
BR - Brasile 2
RU - Federazione Russa 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
CA - Canada 1
CL - Cile 1
DZ - Algeria 1
UA - Ucraina 1
ZA - Sudafrica 1
Totale 344
Città #
Siena 37
Ashburn 14
Dublin 13
Fairfield 13
Santa Cruz 12
Seattle 10
Woodbridge 10
Dong Ket 9
Cambridge 8
Houston 8
Chicago 7
Milan 7
Southend 7
Buffalo 6
Athis-mons 5
Guayaquil 4
Stockholm 4
Wilmington 4
Jakarta 3
Las Vegas 3
London 3
Rome 3
Shanghai 3
Tokyo 3
Catania 2
Durham 2
Florence 2
Kumar 2
Napoli 2
Paris 2
Prato 2
Quito 2
São Paulo 2
Ann Arbor 1
Annaba 1
Bergamo 1
Brussels 1
Cagliari 1
Council Bluffs 1
Crugers 1
Falkenstein 1
Gloucester 1
Henderson 1
Johannesburg 1
Kirkland 1
Lake Forest 1
Lexington 1
Los Angeles 1
Marano Di Napoli 1
Milpitas 1
Minneapolis 1
Montreal 1
Mumbai 1
Munich 1
Nashville 1
New York 1
Numana 1
Paglieta 1
Parma 1
Petritoli 1
Poplar 1
Redmond 1
Rochester 1
Saint Petersburg 1
San Diego 1
San Severo 1
Scranton 1
Triggiano 1
Vicenza 1
Totale 250
Nome #
Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis, file e0feeaa8-497f-44d2-e053-6605fe0a8db0 137
null, file e0feeaa9-5001-44d2-e053-6605fe0a8db0 107
Incidence and risk factors for respiratory tract bacterial colonization and infection in lung transplant recipients, file e0feeaa9-c49d-44d2-e053-6605fe0a8db0 48
Serial KL-6 measurements in COVID-19 patients, file e0feeaa9-6411-44d2-e053-6605fe0a8db0 18
Serial KL-6 analysis in patients with idiopathic pulmonary fibrosis treated with nintedanib, file e0feeaa7-e3d8-44d2-e053-6605fe0a8db0 6
BAL biomarkers’ panel for differential diagnosis of interstitial lung diseases, file e0feeaa8-6197-44d2-e053-6605fe0a8db0 6
Serial KL-6 analysis in patients with idiopathic pulmonary fibrosis treated with nintedanib, file e0feeaa8-12ef-44d2-e053-6605fe0a8db0 5
Regulatory T Cells in Severe Persistent Asthma in the Era of Monoclonal Antibodies Target Therapies, file e0feeaa8-6217-44d2-e053-6605fe0a8db0 4
Bronchoalveolar lavage and serum KL-6 concentrations in chronic hypersensitivity pneumonitis: correlations with radiological and immunological features, file e0feeaa8-adec-44d2-e053-6605fe0a8db0 4
Serum KL-6 concentrations as a novel biomarker of severe COVID-19, file e0feeaa9-0e1f-44d2-e053-6605fe0a8db0 4
Portable Pocket-Sized Ultrasound Scanner for the Evaluation of Lung Involvement in Coronavirus Disease 2019 Patients, file e0feeaa9-4794-44d2-e053-6605fe0a8db0 3
Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis, file f08b5876-aaad-4894-b9a5-5d0d1dcf3d12 3
Lung transplant in patients with familial pulmonary fibrosis, file e0feeaa9-3e4f-44d2-e053-6605fe0a8db0 2
Postoperative acute kidney injury in lung transplant recipients, file e0feeaa8-63d0-44d2-e053-6605fe0a8db0 1
Antithrombin III as predictive indicator of survival in IPF patients treated with Nintedanib: a preliminary study, file e0feeaa8-b15c-44d2-e053-6605fe0a8db0 1
Peripheral biomarkers' panel for severe COVID-19 patients, file e0feeaa9-3a43-44d2-e053-6605fe0a8db0 1
Totale 350
Categoria #
all - tutte 924
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 924


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192 0 0 0 0 0 0 0 0 0 0 0 2
2019/202042 0 0 0 0 0 0 8 16 7 2 5 4
2020/202198 4 3 3 5 1 7 4 10 12 22 14 13
2021/2022108 5 12 8 2 11 7 9 13 8 6 19 8
2022/202354 0 2 16 10 4 12 3 1 1 0 4 1
2023/202444 1 0 1 8 3 9 14 5 0 3 0 0
Totale 350